Direct-to-patient Teledermatology and Computer-assisted Diagnosis

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Primary completion date changed from estimate of Jun 30, 2026 to Aug 31, 2026
    • Study completion pushed from Sep 30, 2026 to Sep 30, 2027
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised at 3 of 3 sites
    • Eligibility criteria expanded, about 4 words
    • Study description expanded, about 3 words
  2. Site details revised at 2 of 3 sitesv10
  3. Primary completion date: Dec 31, 2025 to Jun 30, 2026
    • Site details revised at 1 of 3 sites
    v9
  4. Re-verified, no change to tracked fieldsv8
  5. Start date: Apr 14, 2022 to Nov 7, 2022
    • Study sites: 1 to 3
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2, 2022 to Apr 14, 2022
    • Site details revised
    v6
  2. Start date: Apr 4, 2022 to May 2, 2022v5
  3. Study sites: 3 to 1
    • Start date: Mar 15, 2022 to Apr 4, 2022
    v4
  4. Start date: Feb 1, 2022 to Mar 15, 2022v3
  5. Start date: Dec 6, 2021 to Feb 1, 2022v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.
Trial Details
NCT Number NCT05128006
Lead Sponsor VA Office of Research and Development
Collaborators: VA Boston Healthcare System, Durham VA Health Care System, Providence VA Medical Center
Conditions
(from sponsor)		 New Patient Use of Teledermatology Mobile App
Enrollment 63,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov